108 related articles for article (PubMed ID: 7743549)
1. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
Signorelli KL; Watts LM; Lambert LE
Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
[TBL] [Abstract][Full Text] [Related]
2. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
3. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.
Krieger JI; Karr RW; Grey HM; Yu WY; O'Sullivan D; Batovsky L; Zheng ZL; Colón SM; Gaeta FC; Sidney J
J Immunol; 1991 Apr; 146(7):2331-40. PubMed ID: 1706393
[TBL] [Abstract][Full Text] [Related]
4. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
[TBL] [Abstract][Full Text] [Related]
5. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
[TBL] [Abstract][Full Text] [Related]
6. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
Geluk A; Fu XT; van Meijgaarden KE; Jansen YY; De Vries RR; Karr RW; Ottenhoff TH
Eur J Immunol; 1994 Dec; 24(12):3241-4. PubMed ID: 7805754
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
Olson RR; De Magistris MT; Di Tommaso A; Karr RW
J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
12. Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition.
Brown LR; Nygard NR; Graham MB; Bono C; Braciale VL; Gorka J; Schwartz BD; Braciale TJ
J Immunol; 1991 Oct; 147(8):2677-84. PubMed ID: 1717572
[TBL] [Abstract][Full Text] [Related]
13. Mapping T cell recognition: the identification of a T cell receptor residue critical to the specific interaction with an influenza hemagglutinin peptide.
Wedderburn LR; Searle SJ; Rees AR; Lamb JR; Owen MJ
Eur J Immunol; 1995 Jun; 25(6):1654-62. PubMed ID: 7614994
[TBL] [Abstract][Full Text] [Related]
14. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
15. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis.
Penzotti JE; Doherty D; Lybrand TP; Nepom GT
J Autoimmun; 1996 Apr; 9(2):287-93. PubMed ID: 8738976
[TBL] [Abstract][Full Text] [Related]
16. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
Hill CM; Hayball JD; Allison AA; Rothbard JB
J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions.
Karr RW; Panina-Bordignon P; Yu WY; Lanzavecchia A
J Immunol; 1991 Jun; 146(12):4242-7. PubMed ID: 2040799
[TBL] [Abstract][Full Text] [Related]
18. Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions.
Nepom GT; Ou D; Lybrand TP; DeWeese C; Domeier ME; Buckner JH; Mitchell LA; Tingle AJ
Eur J Immunol; 1996 Apr; 26(4):949-52. PubMed ID: 8625994
[TBL] [Abstract][Full Text] [Related]
19. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
20. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
